Cannabinoid receptor 1 (CB1R), a G-protein-coupled receptor, was reported to be a potential therapeutic target for many central nervous system diseases, such as ischemic stroke, epilepsy, and Parkinson's and Alzheimer's disease [29, 40–42]. The gene discussed is CNR1; the disease is early-onset autosomal dominant Alzheimer disease.